Arrowstreet Capital
AGN

Arrowstreet Capital’s Allergan plc AGN Stock Holding History

Arrowstreet Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,353
Closed -$3.6M – 2521
2020
Q1 		$3.6M Buy
+20,353
New +$3.83M 0.01% 868
2019
Q2 		– Sell
-364,178
Closed -$53.3M – 1887
2019
Q1 		$53.3M Sell
364,178
-256,122
-41% -$37.1M 0.13% 180
2018
Q4 		$82.9M Buy
620,300
+441,900
+248% +$72.4M 0.22% 112
2018
Q3 		$34M Buy
+178,400
New +$32.8M 0.08% 222
2018
Q1 		– Sell
-163,000
Closed -$26.7M – 1433
2017
Q4 		$26.7M Sell
163,000
-133,100
-45% -$23.9M 0.06% 265
2017
Q3 		$60.7M Buy
+296,100
New +$68.9M 0.16% 138
2016
Q4 		– Sell
-2,800
Closed -$645K – 2766
2016
Q3 		$645K Sell
2,800
-638,326
-100% -$156M ﹤0.01% 1183
2016
Q2 		$148M Buy
641,126
+32,025
+5% +$7.38M 0.49% 46
2016
Q1 		$163M Buy
609,101
+344,854
+131% +$98.7M 0.69% 23
2015
Q4 		$82.6M Buy
264,247
+235,024
+804% +$70M 0.38% 56
2015
Q3 		$7.94M Sell
29,223
-422,787
-94% -$130M 0.04% 412
2015
Q2 		$137M Buy
452,010
+357,427
+378% +$107M 0.78% 22
2015
Q1 		$28.1M Sell
94,583
-198,438
-68% -$56.6M 0.17% 136
2014
Q4 		$75.4M Sell
293,021
-2,323
-0.8% -$581K 0.43% 51
2014
Q3 		$71.3M Sell
295,344
-430,791
-59% -$96.4M 0.38% 64
2014
Q2 		$162M Buy
726,135
+302,912
+72% +$62.7M 0.83% 28
2014
Q1 		$87.1M Buy
423,223
+286,395
+209% +$56.7M 0.53% 45
2013
Q4 		$23M Buy
136,828
+115,013
+527% +$18M 0.12% 164
2013
Q3 		$3.14M Sell
21,815
-326,231
-94% -$43.5M 0.02% 464
2013
Q2 		$43.9M Buy
+348,046
New +$39.4M 0.33% 83

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Arrowstreet Capital's AGN Position: Q2 2020 in Review

Arrowstreet Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 20,353 shares — an estimated $3.6M sold.

Arrowstreet Capital first reported a position in AGN in Q2 2013 and held it in 20 quarters. The position peaked at $163M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Arrowstreet Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 20,353 Allergan plc shares in Q2 2020, an estimated $3.6M.
  • Arrowstreet Capital first reported a position in Allergan plc in Q2 2013 and held it in 20 quarters.
  • Arrowstreet Capital's Allergan plc position peaked at $163M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Arrowstreet Capital's 13F filing for Q2 2020, filed 12 Aug 2020.